UniQure N.V. News and Gene Therapy & Biotechnology Innovation Updates

  • Dan Blystone
  • Yesterday
U.S. biotech outlook improves as FDA review stance turns more supportive
Leadership changes at the FDA are starting to reshape sentiment across U.S. biotech after a period of regulatory volatility that erased billions in sector value. A more predictable review approach ...